114 related articles for article (PubMed ID: 27374947)
21. Knockdown of nucleophosmin by RNA interference reverses multidrug resistance in resistant leukemic HL-60 cells.
Lin M; Hu J; Liu T; Li J; Chen B; Chen X
Immunobiology; 2013 Sep; 218(9):1147-54. PubMed ID: 23669237
[TBL] [Abstract][Full Text] [Related]
22. Gene expression profile analysis of SUDHL6 cells with siRNA-mediated BCL11A downregulation.
Wu H; Gao Y; Ding L; He D; Li Y
Cell Biol Int; 2014 Oct; 38(10):1205-14. PubMed ID: 25044937
[TBL] [Abstract][Full Text] [Related]
23. Profiling of gene expression changes caused by p53 gain-of-function mutant alleles in prostate cancer cells.
Tepper CG; Gregg JP; Shi XB; Vinall RL; Baron CA; Ryan PE; Desprez PY; Kung HJ; deVere White RW
Prostate; 2005 Dec; 65(4):375-89. PubMed ID: 16037992
[TBL] [Abstract][Full Text] [Related]
24. [Down-regulatory effect of Nucleostemin expression on signal molecule of PI3K/AKT/mTOR pathway in HL-60 cells].
Jia Y; Wei YY; Zhang F; Li ZB; Liu S; Yue BH
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Feb; 22(1):25-9. PubMed ID: 24598645
[TBL] [Abstract][Full Text] [Related]
25. [Inhibition of vascular endothelial growth factor gene expression and proliferation of leukemia cells by RNA interference].
Shen HL; Xu WL; Wu ZY; Qi YY; Zhong XM; Huang WB; Xiao M
Zhonghua Xue Ye Xue Za Zhi; 2005 Dec; 26(12):710-4. PubMed ID: 16620571
[TBL] [Abstract][Full Text] [Related]
26. Cloning of the nucleostemin gene and its function in transforming human embryonic bone marrow mesenchymal stem cells into F6 tumor cells.
Han C; Zhang X; Xu W; Wang W; Qian H; Chen Y
Int J Mol Med; 2005 Aug; 16(2):205-13. PubMed ID: 16012751
[TBL] [Abstract][Full Text] [Related]
27. Identification of LATS transcriptional targets in HeLa cells using whole human genome oligonucleotide microarray.
Visser S; Yang X
Gene; 2010 Jan; 449(1-2):22-9. PubMed ID: 19799973
[TBL] [Abstract][Full Text] [Related]
28. Lentivirus mediated RNA interference of EMMPRIN (CD147) gene inhibits the proliferation, matrigel invasion and tumor formation of breast cancer cells.
Yang J; Wang R; Li H; Lv Q; Meng W; Yang X
Cancer Biomark; 2016 Jul; 17(2):237-47. PubMed ID: 27434292
[TBL] [Abstract][Full Text] [Related]
29. Recognizing genes differentially regulated in vitro by the multiple endocrine neoplasia type 1 (MEN1) gene, using RNA interference and oligonucleotide microarrays.
Stålberg P; Santesson M; Ekeblad S; Lejonklou MH; Skogseid B
Surgery; 2006 Dec; 140(6):921-9; discussion 929-31. PubMed ID: 17188139
[TBL] [Abstract][Full Text] [Related]
30. [Experimental study on apoptosis of leukemia cell line NB4 transfected with WT1 gene].
Shen HL; Chen ZX; Wang W; Cen JN; Hu SY; Zhao Y
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Dec; 13(6):989-95. PubMed ID: 16403265
[TBL] [Abstract][Full Text] [Related]
31. [Silencing nucleostemin expression reduces the proliferation of PC-3 cells].
Liu RL; Xu Y; Zhang ZH; Wang M; Sun JT; Zhang Y; Li SZ
Zhonghua Nan Ke Xue; 2009 Jul; 15(7):593-8. PubMed ID: 19694370
[TBL] [Abstract][Full Text] [Related]
32. Genome-wide analysis in a murine Dnmt1 knockdown model identifies epigenetically silenced genes in primary human pituitary tumors.
Dudley KJ; Revill K; Whitby P; Clayton RN; Farrell WE
Mol Cancer Res; 2008 Oct; 6(10):1567-74. PubMed ID: 18922972
[TBL] [Abstract][Full Text] [Related]
33. A comprehensive assessment of p53-responsive genes following adenoviral-p53 gene transfer in Bcl-2-expressing prostate cancer cells.
Spurgers KB; Coombes KR; Meyn RE; Gold DL; Logothetis CJ; Johnson TJ; McDonnell TJ
Oncogene; 2004 Mar; 23(9):1712-23. PubMed ID: 14647426
[TBL] [Abstract][Full Text] [Related]
34. Long noncoding RNA, CCDC26, controls myeloid leukemia cell growth through regulation of KIT expression.
Hirano T; Yoshikawa R; Harada H; Harada Y; Ishida A; Yamazaki T
Mol Cancer; 2015 Apr; 14():90. PubMed ID: 25928165
[TBL] [Abstract][Full Text] [Related]
35. Mechanistic insight into WEB-2170-induced apoptosis in human acute myelogenous leukemia cells: the crucial role of PTEN.
Cellai C; Laurenzana A; Bianchi E; Sdelci S; Manfredini R; Vannucchi AM; Caporale R; Balliu M; Mannelli F; Ferrari S; Bosi A; Miniati D; Cocco PL; Veronneau S; Stankova J; Paoletti F
Exp Hematol; 2009 Oct; 37(10):1176-1185.e21. PubMed ID: 19615424
[TBL] [Abstract][Full Text] [Related]
36. Identification of synthetic lethality of PRKDC in MYC-dependent human cancers by pooled shRNA screening.
Zhou Z; Patel M; Ng N; Hsieh MH; Orth AP; Walker JR; Batalov S; Harris JL; Liu J
BMC Cancer; 2014 Dec; 14():944. PubMed ID: 25495526
[TBL] [Abstract][Full Text] [Related]
37. Lentivirus-mediated knockdown of CEP55 suppresses cell proliferation of breast cancer cells.
Wang Y; Jin T; Dai X; Xu J
Biosci Trends; 2016 Feb; 10(1):67-73. PubMed ID: 26902787
[TBL] [Abstract][Full Text] [Related]
38. Mechanism of Mitf inhibition and morphological differentiation effects of hirsein A on B16 melanoma cells revealed by DNA microarray.
Villareal MO; Han J; Ikuta K; Isoda H
J Dermatol Sci; 2012 Jul; 67(1):26-36. PubMed ID: 22564683
[TBL] [Abstract][Full Text] [Related]
39. The candidate oncogene (MCRS1) promotes the growth of human lung cancer cells via the miR-155-Rb1 pathway.
Liu M; Zhou K; Huang Y; Cao Y
J Exp Clin Cancer Res; 2015 Oct; 34():121. PubMed ID: 26467212
[TBL] [Abstract][Full Text] [Related]
40. Systematic analysis of gene expression pattern in has-miR-197 over-expressed human uterine leiomyoma cells.
Ling J; Wu X; Fu Z; Tan J; Xu Q
Biomed Pharmacother; 2015 Oct; 75():226-33. PubMed ID: 26311392
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
